ITRM20050367A1 - Uso del vegf-d o di suoi frammenti funzionalmente attivi per la ricostruzione o per la riparazione ossea. - Google Patents
Uso del vegf-d o di suoi frammenti funzionalmente attivi per la ricostruzione o per la riparazione ossea.Info
- Publication number
- ITRM20050367A1 ITRM20050367A1 IT000367A ITRM20050367A ITRM20050367A1 IT RM20050367 A1 ITRM20050367 A1 IT RM20050367A1 IT 000367 A IT000367 A IT 000367A IT RM20050367 A ITRM20050367 A IT RM20050367A IT RM20050367 A1 ITRM20050367 A1 IT RM20050367A1
- Authority
- IT
- Italy
- Prior art keywords
- vegf
- reconstruction
- active fragments
- functionally active
- bone repair
- Prior art date
Links
- 102000009519 Vascular Endothelial Growth Factor D Human genes 0.000 title 1
- 108010073919 Vascular Endothelial Growth Factor D Proteins 0.000 title 1
- 210000000988 bone and bone Anatomy 0.000 title 1
- 239000012634 fragment Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Vascular Medicine (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000367A ITRM20050367A1 (it) | 2005-07-08 | 2005-07-08 | Uso del vegf-d o di suoi frammenti funzionalmente attivi per la ricostruzione o per la riparazione ossea. |
PCT/IT2006/000433 WO2007007362A2 (en) | 2005-07-08 | 2006-06-09 | Vegf-d and functional fragments thereof for bone repair |
US11/993,825 US20090214495A1 (en) | 2005-07-08 | 2006-06-09 | Vascular endothelial growth factor-d (vegf)-d and functionally fragments thereof for bone repairing |
AU2006267819A AU2006267819A1 (en) | 2005-07-08 | 2006-06-09 | VEGF-D and functional fragments thereof for bone repair |
EP06766317A EP1915392A2 (en) | 2005-07-08 | 2006-06-09 | Vegf-d and functional fragments thereof for bone repair |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000367A ITRM20050367A1 (it) | 2005-07-08 | 2005-07-08 | Uso del vegf-d o di suoi frammenti funzionalmente attivi per la ricostruzione o per la riparazione ossea. |
Publications (1)
Publication Number | Publication Date |
---|---|
ITRM20050367A1 true ITRM20050367A1 (it) | 2007-01-09 |
Family
ID=37602949
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT000367A ITRM20050367A1 (it) | 2005-07-08 | 2005-07-08 | Uso del vegf-d o di suoi frammenti funzionalmente attivi per la ricostruzione o per la riparazione ossea. |
Country Status (5)
Country | Link |
---|---|
US (1) | US20090214495A1 (it) |
EP (1) | EP1915392A2 (it) |
AU (1) | AU2006267819A1 (it) |
IT (1) | ITRM20050367A1 (it) |
WO (1) | WO2007007362A2 (it) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3773677B1 (en) * | 2018-04-12 | 2025-04-02 | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. | Anti-aging compositions and methods of use |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5763416A (en) * | 1994-02-18 | 1998-06-09 | The Regent Of The University Of Michigan | Gene transfer into bone cells and tissues |
US5942496A (en) * | 1994-02-18 | 1999-08-24 | The Regent Of The University Of Michigan | Methods and compositions for multiple gene transfer into bone cells |
ES2239338T5 (es) * | 1995-09-29 | 2013-05-31 | Vegenics Pty Ltd | Genes regulados y sus usos |
WO2005030240A2 (en) * | 2003-09-23 | 2005-04-07 | Ludwig Institute For Cancer Research | Vege-cor vege-d materials and methods for stimulation of neural stem cells |
US20050043235A1 (en) * | 2003-06-12 | 2005-02-24 | Kari Alitalo | Use of VEGF-C or VEGF-D in reconstructive surgery |
US20060039949A1 (en) * | 2004-08-20 | 2006-02-23 | Nycz Jeffrey H | Acetabular cup with controlled release of an osteoinductive formulation |
-
2005
- 2005-07-08 IT IT000367A patent/ITRM20050367A1/it unknown
-
2006
- 2006-06-09 WO PCT/IT2006/000433 patent/WO2007007362A2/en active Application Filing
- 2006-06-09 EP EP06766317A patent/EP1915392A2/en not_active Withdrawn
- 2006-06-09 AU AU2006267819A patent/AU2006267819A1/en not_active Abandoned
- 2006-06-09 US US11/993,825 patent/US20090214495A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2006267819A1 (en) | 2007-01-18 |
WO2007007362A3 (en) | 2007-06-28 |
EP1915392A2 (en) | 2008-04-30 |
WO2007007362A2 (en) | 2007-01-18 |
US20090214495A1 (en) | 2009-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0911203A2 (pt) | peptídeo ou derivado de peptídeo, composição farmacêutica, uso de um peptídeo ou derivado de peptídeo, métodos para tratar um paciente tendo uma deficiencia e para preparar o peptídeo ou derivado de peptídeo. | |
LTC2100614I2 (lt) | Antikūnas prieš PDGFR-alfa, skirtas naudoti auglių gydymui | |
BRPI0717219A2 (pt) | "composição imunogênica, método para tratar ou prevenir doença, e, uso de uma composição imunogênica." | |
BRPI0907663A2 (pt) | ''composição que compreende hfo- 123 yf, composição que compreende hcfc-243db, composição que compreende hcfo- 1233xf, composição que comproeende hcfc- 244bb, uso das composições e método de uso das composições. | |
BRPI0920111A2 (pt) | dispositivo corrediço unidirecional para implantes de fixação intramedulares e intertrocantéricos. | |
FR2884136B1 (fr) | Implant chirurgical intervertebral formant rotule | |
MEP59208A (en) | Activin-actriia antagonists and uses for promoting bone growth | |
BRPI0619585A2 (pt) | aparelho para aumento osteopático | |
FR2935601B1 (fr) | Implant intramedullaire resorbable entre deux os ou deux fragments osseux | |
CL2007002642A1 (es) | Compuestos derivados de 3-(6-oxo-1,6-dihidro-piridin-3-il)-benzamida; composicion farmaceutica; y uso en el tratamiento del cancer. | |
BRPI0614205A2 (pt) | composto, composição farmacêutica, e, uso de composto | |
DE602006003922D1 (de) | Chirurgisches Implantat | |
EP1854415A4 (en) | SURGICAL TREATMENT DEVICE | |
BRPI0813563A2 (pt) | Implante de tecido ósseo compreendendo íons de estrôncio | |
EP1863899A4 (en) | COMPOSITIONS FOR TREATING SKIN | |
DK1827412T3 (da) | Sammensætninger til anvendelse i kirurgi | |
EP1917978A4 (en) | MEANS OF PREVENTING PREVIOUS OVULATION | |
IT1391866B1 (it) | Composizione iniettabile di polinucleotidi per il trattamento di patologie osteoarticolari. | |
BRPI0815768A2 (pt) | Uso de absorventes de uv, e, composição cosmética. | |
BRPI0720323A2 (pt) | composto, método de tratamento, composição farmacêutica e uso do composto | |
CL2007002769A1 (es) | Compuestos derivados de sulfonamida; procedimiento de obtencion; composicion farmaceutica; y uso en el tratamiento de la diabetes. | |
PT2056805E (pt) | Utilização de derivados de 2,5-di-hidroxibenzeno para o tratamento de reacção tecidular | |
BRPI0615630A2 (pt) | composição farmacêutica, e, uso de sertindol | |
ITRM20050367A1 (it) | Uso del vegf-d o di suoi frammenti funzionalmente attivi per la ricostruzione o per la riparazione ossea. | |
ITRM20060688A1 (it) | 2-6-difenil-4,8diazoadamantan-1-one e suoi derivati suo procedimento di preparazione e suo uso per la formulazione di soluzioni ad azione sterilizzante e disinfettante |